APA (7th ed.) Citation

ES, M., LB, S., AAM, v. d. V., J, W., L, A., MC, H., . . . A, I. (2026). Phase 1 Study of [177Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 67(2), 262. https://doi.org/10.2967/jnumed.125.270411

Chicago Style (17th ed.) Citation

ES, Mittra, et al. "Phase 1 Study of [177Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 67, no. 2 (2026): 262. https://doi.org/10.2967/jnumed.125.270411.

MLA (9th ed.) Citation

ES, Mittra, et al. "Phase 1 Study of [177Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 67, no. 2, 2026, p. 262, https://doi.org/10.2967/jnumed.125.270411.